| P50 | author | Martin Jakobs | Q64777099 |
| P2093 | author name string | Raphaela Fritsche-Guenthe | |
| P2860 | cites work | Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity | Q33231553 |
| | Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes | Q35630052 |
| | Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy | Q36153729 |
| | Seprase: an overview of an important matrix serine protease | Q37080563 |
| | Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. | Q40151296 |
| | Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts | Q43162044 |
| | [MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis]. | Q45931894 |
| | PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. | Q51998799 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 3513-4; author reply 3514-5 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Specificity of inhibitors and frequency of expression of target proteins used to study cartilage invasion by rheumatoid arthritis synovial fibroblasts: comment on the article by Ospelt et al | |
| | Specificity of inhibitors and frequency of expression of target proteins used to study cartilage invasion by rheumatoid arthritis synovial fibroblasts: Comment on the article by Ospelt et al | |
| P478 | volume | 62 | |